Cinnamomum spp.
Cinnamon is a widely used spice derived from the bark of Cinnamomum species. It has been studied for its potential effects on blood glucose regulation, lipid metabolism, and inflammation.
In a longevity context, cinnamon is particularly relevant due to its potential to support glycaemic control and cardiometabolic health.
Cinnamon contains several bioactivecompounds, including:
- Cinnamaldehyde
- Polyphenols
- Procyanidins
These compounds are thought to influence insulin signalling and glucosemetabolism.
Cinnamon has been shown to reduce fasting blood glucose in several human trials.
Some studies report reductions in triglycerides and LDL cholesterol.
Cinnamon may improve insulin signalling and glucose uptake.
Adds flavour and polyphenol diversity to the formulation.
Randomised controlled trial · Adults with type 2 diabetes · 40 days
Cinnamon reduced fasting blood glucose, triglycerides, LDL cholesterol, and total cholesterol.
View study on PubMed →Systematic review and meta-analysis of RCTs
Cinnamon supplementation significantly reduced fasting blood glucose, with smaller or inconsistent effects on HbA1c.
View study on PubMed →Cinnamon is a well-studied spice with evidence supporting its role in blood glucose regulation and cardiometabolic health. Its effects are generally modest but consistent, making it a useful component of a broader longevity-focused dietary approach.
← Back to Daily DiversityFurther reading on Healthline →